Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy

Case Report: Pathological Complete Response in a Brain-Metastatic Lung Squamous Cell Carcinoma Patient With Long-Term Benefit From Chemo-Immunotherapy

Immune checkpoint inhibitors have brought long-term survival benefit in advanced non-small cell lung cancer patients without driver gene mutations. Even after withdrawal of immunotherapy for a maximum of two years, some patients still benefit from this therapy and the reason is not fully clear. Resu...

Full description

Bibliographic Details
Main Authors: Chen Hu, Qiang Ma, Nengsheng Li, Nuo Luo, Shuai Hao, Minrui Jiang, Fei Pang, Yan Yang, Li Li, Yong He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
NSCLC
immunotherapy
neoadjuvant therapy
pathological complete response (PCR)
immune checkpoint inhibitors (ICI)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.693704/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.693704/full

Similar Items